Back to resultsInsulin, Neurogenetics and Memory in Alzheimer's Disease
Primary Purpose
Alzheimer Disease
Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
rosiglitazone
Sponsored by
About this trial
This is an interventional treatment trial for Alzheimer Disease
Eligibility Criteria
Men and women with mild Alzheimer's Disease without serious medical or psychiatric comorbid conditions.
Sites / Locations
- VA Puget Sound Health Care System
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
NCT ID
NCT00018382
First Posted
July 3, 2001
Last Updated
January 20, 2009
Sponsor
US Department of Veterans Affairs
1. Study Identification
Unique Protocol Identification Number
NCT00018382
Brief Title
Insulin, Neurogenetics and Memory in Alzheimer's Disease
Official Title
Insulin, Neurogenetics and Memory in Alzheimer's Disease: A Novel Therapeutic Approach
Study Type
Interventional
2. Study Status
Record Verification Date
December 2004
Overall Recruitment Status
Completed
Study Start Date
October 1999 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
March 2003 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
US Department of Veterans Affairs
4. Oversight
5. Study Description
Brief Summary
This study examines the use of insulin-sensitizing compounds, as therapeutic agents for cognitive impairment in Alzheimer's disease.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Alzheimer Disease
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Masking
Double
Allocation
Randomized
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
rosiglitazone
10. Eligibility
Sex
All
Minimum Age & Unit of Time
55 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Men and women with mild Alzheimer's Disease without serious medical or psychiatric comorbid conditions.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Steven Kahn, M.D.
First Name & Middle Initial & Last Name & Degree
Sanjay Asthana, M.D.
First Name & Middle Initial & Last Name & Degree
Alfred Fujimoto, M.D.
Facility Information:
Facility Name
VA Puget Sound Health Care System
City
Seattle
State/Province
Washington
ZIP/Postal Code
98108
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Insulin, Neurogenetics and Memory in Alzheimer's Disease
We'll reach out to this number within 24 hrs